İki Ayda Bir Enjektabl Uzun Etkili Cabotegravir + Rilpivirin (CAB + RPV) Tedavi Rejimi: ATLAS-2M Çalışması 152. Hafta Sonuçları.

Autor: Overton, Edgar T., Richmond, Gary, Rizzardini, Giuliano, Thalme, Anders, Girard, Pierre Marie, Wong, Alexander, Porteiro, Norma, Español, Carlos Martín, Acuipil, Carolina, Aksar, Asma, Yuanyuan Wang, D’amico, Ronald, Talarico, Christine, Vandermeulen, Kati, Spreen, William R., Paracıklı, Gürcan
Zdroj: Mediterranean Journal of Infection, Microbes & Antimicrobials; 2022 Supplement, Vol. 11, p129-129, 1p
Databáze: Complementary Index